Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan · Delayed Price · Currency is TWD 16.85
-0.45 (-2.60%)
Sep 8, 2026, 1:08 PM CST
Anxo Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 323.91 | 363.37 | 358.92 | 295.43 | 241.32 | 214.18 |
Short-Term Investments | - | - | 2.23 | 89.75 | - | - |
Cash & Short-Term Investments | 323.91 | 363.37 | 361.14 | 385.18 | 241.32 | 214.18 |
Cash Growth | 3.05% | 0.62% | -6.24% | 59.61% | 12.67% | 3.09% |
Accounts Receivable | 205.14 | 178.62 | 210.5 | 249.71 | 240.86 | 208.64 |
Other Receivables | 15.32 | 9.05 | 4.67 | 11.36 | 10.63 | 10.42 |
Receivables | 220.46 | 187.67 | 215.17 | 261.07 | 251.49 | 219.07 |
Inventory | 259.98 | 253.82 | 262.42 | 283.86 | 243.1 | 238.88 |
Prepaid Expenses | 29.78 | 18.92 | 18.15 | 22.19 | 14.88 | 17.11 |
Other Current Assets | 11.55 | 24.16 | 21.69 | 25.99 | 20.7 | 15.54 |
Total Current Assets | 845.68 | 847.94 | 878.56 | 978.29 | 771.5 | 704.78 |
Property, Plant & Equipment | 997.41 | 1,022 | 1,038 | 1,079 | 1,110 | 1,140 |
Long-Term Investments | 57.78 | 57.78 | 52.56 | 30 | - | - |
Goodwill | 36.61 | 36.61 | 36.61 | 36.61 | 36.61 | 36.61 |
Other Intangible Assets | 6.55 | 7.86 | 9.84 | 3.77 | 4.95 | 4.3 |
Long-Term Deferred Tax Assets | 48.44 | 44.22 | 34.38 | 22.03 | 18.75 | 11.77 |
Other Long-Term Assets | 87.23 | 50.42 | 57.8 | 68.82 | 32.79 | 21.81 |
Total Assets | 2,080 | 2,067 | 2,108 | 2,219 | 1,974 | 1,919 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 82.06 | 64.95 | 81.55 | 79.69 | 94.03 | 78.43 |
Accrued Expenses | 68.61 | 83.05 | 88.43 | 75.35 | 71.58 | 66.73 |
Short-Term Debt | 305 | 268 | 205 | 215 | 256.38 | 215 |
Current Portion of Long-Term Debt | 54.67 | 58.6 | 63.46 | 58.5 | 57.55 | 64.68 |
Current Portion of Leases | 12.45 | 13.62 | 9.36 | 14.65 | 11.5 | 8.69 |
Current Income Taxes Payable | - | - | - | 6.68 | 6.76 | 4.33 |
Current Unearned Revenue | 28.73 | 21.6 | 20.07 | 5.43 | 14.47 | 5.04 |
Other Current Liabilities | 33.36 | 29.67 | 34.76 | 31.42 | 42.8 | 29.95 |
Total Current Liabilities | 584.87 | 539.48 | 502.61 | 486.72 | 555.07 | 472.84 |
Long-Term Debt | 367.42 | 388.8 | 437.61 | 480.7 | 528.08 | 572.61 |
Long-Term Leases | 1.93 | 5.95 | 11.2 | 19 | 33.57 | 21.49 |
Long-Term Unearned Revenue | 15.06 | 16.4 | 16.21 | 27.73 | 26.49 | 18.09 |
Long-Term Deferred Tax Liabilities | 0.05 | 0.16 | - | - | - | - |
Other Long-Term Liabilities | 9.28 | 7.91 | 0.58 | 1.19 | 1.26 | 2.02 |
Total Liabilities | 978.62 | 958.7 | 968.21 | 1,015 | 1,144 | 1,087 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 560.39 | 558.71 | 558.14 | 556.64 | 481.64 | 481.64 |
Additional Paid-In Capital | 426.72 | 459.35 | 483.68 | 478.85 | 211.08 | 206.62 |
Retained Earnings | -6.59 | -34.13 | -25.46 | 54.01 | 32.14 | 44.7 |
Comprehensive Income & Other | 6 | 7.83 | 6 | - | - | - |
Total Common Equity | 986.52 | 991.76 | 1,022 | 1,089 | 724.86 | 732.96 |
Minority Interest | 114.58 | 116.37 | 117 | 113.76 | 104.78 | 98.99 |
Shareholders' Equity | 1,101 | 1,108 | 1,139 | 1,203 | 829.64 | 831.94 |
Total Liabilities & Equity | 2,080 | 2,067 | 2,108 | 2,219 | 1,974 | 1,919 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 741.46 | 734.97 | 726.63 | 787.84 | 887.09 | 882.47 |
Net Cash (Debt) | -417.55 | -371.6 | -365.49 | -402.66 | -645.76 | -668.29 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.46 | -6.65 | -6.56 | -7.81 | -13.41 | -13.78 |
Filing Date Shares Outstanding | 56.04 | 55.87 | 55.81 | 55.66 | 48.16 | 48.16 |
Total Common Shares Outstanding | 56.04 | 55.87 | 55.81 | 55.66 | 48.16 | 48.16 |
Working Capital | 260.81 | 308.45 | 375.94 | 491.57 | 216.43 | 231.93 |
Book Value Per Share | 17.60 | 17.75 | 18.32 | 19.57 | 15.05 | 15.22 |
Tangible Book Value | 943.36 | 947.28 | 975.92 | 1,049 | 683.3 | 692.04 |
Tangible Book Value Per Share | 16.83 | 16.95 | 17.49 | 18.85 | 14.19 | 14.37 |
Land | 576.53 | 576.53 | 576.53 | 576.53 | 576.53 | 576.53 |
Buildings | 425.33 | 423.96 | 417.99 | 417.99 | 416.05 | 417.89 |
Machinery | 494.27 | 501.41 | 463.03 | 464.55 | 434.6 | 436.82 |
Construction In Progress | 11.62 | 5.91 | 9.88 | - | - | - |
Leasehold Improvements | 14.94 | 14.5 | 15.9 | 3.99 | 2.02 | 10.09 |